NDC 11822-0475-01 - childrens allergy relief
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11822-0475
- Requested NDC
- 11822-0475-01
- Package NDCs from labels
- 11822-0475-1, 11822-0475-0, 11822-0475-01
- Manufacturer
- Rite Aid Corporation
- Effective date
- 2026-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| childrens allergy relief - Rite Aid Corporation | Rite Aid Corporation | 2026-07-24 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11822-0475-0 | childrens allergy relief | 1 in 1 CARTON | SOLUTION | 1 | 5 | |
| 11822-0475-0 | childrens allergy relief | 240 mL in 1 BOTTLE | SOLUTION | 240 | 5 | |
| 11822-0475-1 | childrens allergy relief | 1 in 1 CARTON | SOLUTION | 1 | 5 | |
| 11822-0475-1 | childrens allergy relief | 118 mL in 1 BOTTLE | SOLUTION | 118 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11822-0475 | CHILDRENS ALLERGY RELIEF (CETIRIZINE HCL) SOLUTION [RITE AID CORPORATION] | 5 | Current NDC, Legacy NDC, 4 package rows | 20250508_09474431-cf46-45da-8b20-9551ddea28a7.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CETIRIZINE HYDROCHLORIDE | CETIRIZINE HYDROCHLORIDE | Bionpharma Inc. | 831d4141-b3be-4d98-a372-9c4d57ad296c | 2025-12-08 | Warnings | 64O047KTOA |
| Sodium phenylacetate and Sodium benzoate | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Navinta LLC | d20768fe-4516-483a-a082-ff1df9ad1d99 | 2025-12-06 | Warnings, Adverse reactions | OJ245FE5EU |
| Cetirizine | CETIRIZINE HYDROCHLORIDE | A-S Medication Solutions | ff782956-03b7-4ae6-b78f-fb7fe78b262d | 2025-12-05 | Warnings | 64O047KTOA |
| Alka-Seltzer Extra Strength | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE, AND ASPIRIN | Bayer HealthCare LLC. | 49b73bd5-6465-05eb-e054-00144ff88e88 | 2025-12-04 | Warnings | XF417D3PSL |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | Bayer HealthCare LLC. | 5be36a7f-7d1f-468d-9c29-92c8cd3ef1bc | 2025-12-04 | Warnings | XF417D3PSL |
| Cetirizine | CETIRIZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 4a45672b-67d3-4739-86ec-0a6696dd83d4 | 2025-12-04 | Warnings | 64O047KTOA |
| signature care allergy relief | CETIRIZINE HYDROCHLORIDE | Safeway | 24099cbf-61ee-4ec8-a4ec-95a66ceaa0c0 | 2025-12-04 | Warnings | 64O047KTOA |
| CAREALL Allergy Relief | CETIRIZINE HCL | New World Imports | d3411eec-05b1-49b3-86e8-bc47ac0ef6b7 | 2025-12-01 | Warnings | 64O047KTOA |
| Splash Pure PF | PROPYLENE GLYCOL | LABORATORIOS SOPHIA, S.A. DE C.V. | 40ad7ae5-1f2a-e3b1-e063-6294a90a6f84 | 2025-11-26 | Warnings | 6DC9Q167V3 |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | ab19b011-0a51-4f04-9881-d9fc7cae95ae | 2025-11-25 | XF417D3PSL | |
| Cetirizine HCl | CETIRIZINE HCL | KROGER COMPANY | 63ddeea4-d701-42b2-bcb7-81c0e43eb013 | 2025-11-24 | Warnings | 64O047KTOA |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | 059QF0KO0R |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | 059QF0KO0R |
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
| Eyewash Station Additive Concentrate | CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL | Niagara Pharmaceuticals Inc. | 362a6b6d-862d-4322-87a8-5b3a07fbe174 | 2025-11-24 | Warnings | 6DC9Q167V3 |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 777e1559-786f-8d54-e053-2991aa0aa98d | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 7289103a-5cbf-42f4-8848-e827149a43ca | 2025-11-24 | Warnings | 059QF0KO0R |
| Eyewash Additive Concentrate | WATER AND PROPYLENE GLYCOL | Haws Corporation | dd168403-398c-41ff-b1df-d93e4ff39de3 | 2025-11-20 | Warnings | 6DC9Q167V3 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.